MEPs approve new rules on safer cosmetics

Published: 25 March 2009 y., Wednesday

Makiažas
Parliament approved an update of EU legislation on cosmetics when it votes on a first-reading agreement thrashed out between EP and Council representatives. The basic aim of the new regulation is to remove legal uncertainties and inconsistencies, while increasing the safety of cosmetics. Parliament's amendments add further improvements, especially regarding the claims companies make for their products and the safety of nanomaterials used in cosmetics.

This legislation has been guided through Parliament by Dagmar Roth-Behrend (PES, DE). Many of Parliament's wishes have been taken on board in the final text of the regulation. The legislative resolution was adopted with 633 votes in favour, 29 against with 11 abstentions.
 
Broad backing for Commission proposal
 
MEPs agreed from the outset with the Commission's approach of simplifying EU law on cosmetics by replacing the 27 sets of national legislation that enacted the old cosmetics directive with a single regulation - a standard legal text directly applicable in all Member States.  They also supported the essential aims of the new proposal: ensuring a high level of safety of cosmetic products in future by strengthening manufacturer responsibility and in-market control aspects while cutting red tape.  The existing provisions banning animal testing for finished cosmetic products as of 2004, with a phasing-out period for animal tests on cosmetic ingredients by 2009/2013, are unaffected by the new regulation.
 
Nanomaterials: labelling, definition and safety assessment needed
 
If cosmetics ingredients include nanomaterials, as happens increasingly, safety concerns must be paramount, says the compromise between EP and Council. 
 
The Commission estimated in 2006 that about 5% of cosmetic products contained nanoparticles. As requested by the European Parliament, the new regulation introduces a safety assessment procedure for all products containing nanomaterials, which could lead to a ban on a substance if there is a risk to human health. MEPs also pushed successfully for any nanomaterials present in cosmetics to be mentioned in the list of ingredients on the packaging.
 
Thanks to Parliament, a definition of nanomaterials is also introduced in the regulation and this must be adapted by the Commission in line with scientific and technological advances. The definition introduced by MEPs is as follows: “'nanomaterial' means an insoluble or bioresistant and intentionally manufactured material with one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm”.
 
Product claims: common criteria for use needed
 
On the use of product claims for cosmetics (such as claims about their effectiveness) the regulation seeks to ensure that only the real effects of a product can be mentioned in advertising and labelling. The Commission is asked to draw up an action plan on such claims and to adopt a list of common criteria for their use.
 
Substances classified as carcinogenic, mutagenic or toxic for reproduction
 
As proposed by the Commission and supported by MEPs, the regulation provides for strict rules for the use of substances in cosmetics which are carcinogenic, mutagenic or toxic for reproduction (CMR). The use of those substances is basically forbidden and they can only be used in exceptional cases under strict conditions, which have been tightened up by the compromise.
 
Date of entry into force
 
The regulation - which is directly applicable in all Member States - will enter into force 20 days after publication in the EU Official Journal. It will apply 42 month later - except for certain parts on CMR substances and nanomaterials, which will apply from an earlier stage.
 
Background: the 2003 cosmetics directive
 
The last time this topic came before Parliament, MEPs fought hard and successfully for a ban on sales of any animal-tested cosmetic products and ingredients, including those from outside the EU (see link below).   Animal testing of finished cosmetic products was outlawed from 2004. In addition, bans were to be phased in for animal testing of cosmetics ingredients and also - to make sure that imports are covered - on any sales in the EU of animal-tested products and ingredients.
 
The deal will allow the continued use of ethanol in cosmetics, which is widely used and is the base of most perfumes. There are also provisions which will reduce the regulatory burden on industry, without lowering safety, which sit alongside a requirement to notify nanomaterials and to mark them on the ingredient list.

 

Šaltinis: europarl.europa.eu
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.

Facebook Comments

New comment


Captcha

Associated articles

The most popular articles

Newly Trained Village Doctors are Medical ‘Jack-of-All-Trades’

The only physician in her village of Tsoniarisi, Mzevinar Bolkvadze sees patients all day in a newly built and equipped ambulatory. more »

Over 49 000 cases of pandemic (H1N1) 2009 in Europe

As of 7 September 2009, 48 of the 53 Member States in the WHO European Region had reported over 49 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection. more »

China nearer to mass flu jab

China's food and drug administration say clinical trials of a vaccine against the H1N1 flu strain have been successful. more »

Kyrgyzstan reports first cases of pandemic (H1N1) 2009

As of 31 August 2009, 48 of the 53 Member States in the WHO European Region had reported laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection. more »

EU Health Security Committee agrees statement on target and priority groups for vaccination

The European Union Health Security Committee and the Early Warning and Response authorities adopted a policy statement proposed by the European Commission which outlines a shared European approach towards identifying target and priority groups for A H1N1 vaccination. more »

Over 42 000 cases of pandemic (H1N1) 2009 in Europe; Belarus reports first case

As of 20 August 2009, 47 of the 53 Member States in the WHO European Region had reported over 42 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection. more »

WHO/Europe presents European experiences on physical activity promotion at major conference in the United States

About 1000 participants, mostly from North America, debated solutions to the obesity epidemic in the United States (US) at the Weight of the Nation conference, organized in Washington, USA, by the US Centers for Disease Control. more »

EU Health Security Committee agrees statements on school closures and travel advice

The European Union Health Security Committee and the Early Warning and Response authorities (HSC/EWRS) unanimously adopted for the first time two policy statements proposed by the European Commission on public health measures for pandemic influenza A (H1N1) 2009. more »

Over 33 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection in Europe

As of 10 August 2009, 46 of the 53 countries in the WHO European Region had reported over 33 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection, including 55 fatalities in 7 countries. more »

Moog Medical Devices to Invest EUR 2M in Lithuania and Establish Services Centre

The U.S. company Moog Medical Devices which acquired the company the Lithuanian Viltechmeda at the beginning of the year 2009, intends to invest EUR 2M in Lithuania in the nearest future, to establish a modern services centre. more »